UA6537U - Scheme for prescribing carvedilol to patients with chronic cardiac insufficiency and concomitant arterial hypertension - Google Patents
Scheme for prescribing carvedilol to patients with chronic cardiac insufficiency and concomitant arterial hypertensionInfo
- Publication number
- UA6537U UA6537U UA20040907797U UA20040907797U UA6537U UA 6537 U UA6537 U UA 6537U UA 20040907797 U UA20040907797 U UA 20040907797U UA 20040907797 U UA20040907797 U UA 20040907797U UA 6537 U UA6537 U UA 6537U
- Authority
- UA
- Ukraine
- Prior art keywords
- carvedilol
- patients
- cardiac insufficiency
- chronic cardiac
- prescribing
- Prior art date
Links
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title abstract 5
- 229960004195 carvedilol Drugs 0.000 title abstract 5
- 206010019280 Heart failures Diseases 0.000 title abstract 4
- 230000001684 chronic effect Effects 0.000 title abstract 4
- 208000037849 arterial hypertension Diseases 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004448 titration Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
The scheme for prescribing Carvedilol to the patients with the chronic cardiac insufficiency and the concomitant arterial hypertension consists in increasing the initial dose and escalating the titration dose increment. The patients with the chronic cardiac insufficiency of functional class I-II are given 25 mg of Carvedilol daily divided in two doses for 7-14 days. Then, the patients are given 37.5 mg of Carvedilol daily divided in two doses for further 7-14 days. If the drug is tolerated well, the daily dose increases up to 50 mg. The patients with the chronic cardiac insufficiency of functional class III are given initially 12.5 mg of Carvedilol daily divided in two doses for 7-14 days. If the drug is tolerated well, the daily dose increases by 12.5 mg up to 50 mg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20040907797U UA6537U (en) | 2004-09-24 | 2004-09-24 | Scheme for prescribing carvedilol to patients with chronic cardiac insufficiency and concomitant arterial hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20040907797U UA6537U (en) | 2004-09-24 | 2004-09-24 | Scheme for prescribing carvedilol to patients with chronic cardiac insufficiency and concomitant arterial hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA6537U true UA6537U (en) | 2005-05-16 |
Family
ID=34883212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20040907797U UA6537U (en) | 2004-09-24 | 2004-09-24 | Scheme for prescribing carvedilol to patients with chronic cardiac insufficiency and concomitant arterial hypertension |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA6537U (en) |
-
2004
- 2004-09-24 UA UA20040907797U patent/UA6537U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roy et al. | Lycorine: A prospective natural lead for anticancer drug discovery | |
| MY159353A (en) | Pirfenidone treatment for patients with atypical liver function | |
| EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
| NO20075323L (en) | Nutritional preparation for HIV patients | |
| UA105191C2 (en) | Treatment with pirfenidone of patients with abnormal liver function | |
| ATE405272T1 (en) | TREATMENT OF T-CELL LYMPHOMA USING 10-PROPARGYL-10-DEAZAAMINOPTERIN | |
| UA6537U (en) | Scheme for prescribing carvedilol to patients with chronic cardiac insufficiency and concomitant arterial hypertension | |
| CR8059A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE SUBSTANCES | |
| EA200800075A1 (en) | DOSING CIRCUIT FOR WISE | |
| DK1675611T3 (en) | Therapeutic uses for C-peptide | |
| AR049135A1 (en) | COMPOSITION, METHOD, KIT AND TREATMENT WITH OXALIPLATIN AND AN EGFR INHIBITOR, AS ERLOTINIB | |
| NO20061515L (en) | Use of oxcarbazepine for the treatment of diabetic neurpathic pain and improvement of sleep | |
| UA53291U (en) | Method for treating endothelial dysfunction in aged patients with chronic heart failure | |
| TW200515912A (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| UA33293U (en) | Method for treating chronic endometritis | |
| RU2009116087A (en) | METHOD FOR MEDICINAL REDUCTION OF OXIDATIVE STRESS LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION | |
| MD3424F1 (en) | Method of treating the essential hypertension associated with marked anxious states and neuroses | |
| UA41236U (en) | Method for treating chronic systolic cardiac insufficiency | |
| UA89009C2 (en) | Method for treating community-acquired pneumonia | |
| RU2004107473A (en) | METHOD FOR THERAPY OF CHRONIC OVERSTRAINING OF AN ATHLETES | |
| RU2007113591A (en) | METHOD FOR TREATING PLATELET DYSFUNCTIONS IN PERSONS AFFECTING A METABOLIC SYNDROME | |
| UA83947U (en) | Method for treatment of congestive heart failure combined with diabetes mellitus type 2 with disynchrony | |
| UA64176U (en) | Method for correcting cerebral reactivity in patients with arterial hypertension and concomitant cerebral ischemia | |
| UA114594U (en) | METHOD OF TREATMENT OF PSORIASIS WITH CONCENTRAL ARTERIAL HYPERTENSION | |
| UA39501U (en) | Method for treating stroke |